Sub navigation menu:
You are here: You are here > Products > Global X China Biotech ETF > Portfolio holdings
Global X China Biotech ETF
Daily holdings
| Total Net Asset Value (in HKD) | Number of Securities [1] | Securities (%) | Cash and Cash Equivalent (%) |
|---|---|---|---|
| $ {{ dailyTotalNetAssetValueHKD | number:2 }} | {{ dailyNumberOfSecurities }} | {{ dailySecurities | number:2 }} | {{ dailyCashAndCashEquiv | number:2 }} |
| Total Net Asset Value (in USD)[2] | Number of Securities [1] | Securities (%) | Cash and Cash Equivalent (%) |
|---|---|---|---|
| $ {{ dailyTotalNetAssetValueUSD | number:2}} | {{ dailyNumberOfSecurities }} | {{ dailySecurities | number:2}} | {{ dailyCashAndCashEquiv | number:2}} |
| Name of Securities | Exchange Ticker | Exchange | Market Price (in RMB) | Number of Shares Held | Market Value (in RMB) | % of the Net Asset of the Fund [3] |
|---|---|---|---|---|---|---|
| {{x.securityName}} | {{x.ticker}} | {{x.equityPrimaryExchange}} | {{x.marketPrice}} | {{x.quantity}} | {{x.marketValue}} | {{x.weightingPercentage}} % |
Month-end holdings
| Total Net Asset Value (in HKD) | Number of Securities [1] | Securities (%) | Cash and Cash Equivalent (%) |
|---|---|---|---|
| $ {{ monthEndTotalNetAssetValueHKD | number:2}} | {{ monthEndNumberOfSecurities}} | {{ monthEndSecurities | number:2}} | {{ monthEndCashAndCashEquiv | number:2}} |
| Total Net Asset Value (in USD)[2] | Number of Securities [1] | Securities (%) | Cash and Cash Equivalent (%) |
|---|---|---|---|
| $ {{ monthEndTotalNetAssetValueUSD | number:2}} | {{ monthEndNumberOfSecurities}} | {{ monthEndSecurities | number:2}} | {{ monthEndCashAndCashEquiv | number:2}} |
| Name of Securities | Exchange Ticker | Exchange | Market Price (in RMB) | Number of Shares Held | Market Value (in RMB) | % of the Net Asset of the Fund [3] |
|---|---|---|---|---|---|---|
| {{x.securityName}} | {{x.ticker}} | {{x.equityPrimaryExchange}} | {{x.marketPrice}} | {{x.quantity}} | {{x.marketValue}} | {{x.weightingPercentage}} % |
All dates are in GMT+8 Time, unless otherwise specified.
- [1]
- Number of Securities represents the number of underlying securities held by the Fund.
- [2]
- All dollar amounts in USD are indicative and for reference only.
- [3]
- The sum of all the allocation percentages shown in the table above may not equal 100% due to rounding or omissions of holdings of less than 1%.
Disclaimer:
- Certain information contained in this website is compiled from third party sources. Whilst Mirae Asset Global Investments (Hong Kong) Limited (“Mirae Asset HK”) has, to the best of its endeavor, ensured that such information is accurate, complete and up-to-date, and has taken care in accurately reproducing the information, it shall have no responsibility or liability whatsoever for the accuracy of such information or any use or reliance thereof. Mirae Asset HK accepts no liability for any loss or damage of any kind resulting out of the unauthorized use of this website. The information contained in this website is for information purposes only and does not constitute any recommendation, offer or solicitation to buy, sell or subscribe to any securities or financial instruments in any jurisdiction. Investment involves risk. It cannot be guaranteed that the performance of the Fund will generate a return and there may be circumstances where no return is generated or the amount invested is lost. Past performance is not indicative of future performance. Before making any investment decision to invest in the Fund, investors should read the Fund’s prospectus for details and the risk factors. Investors should ensure they fully understand the risks associated with the Fund and should also consider their own investment objective and risk tolerance level. Investors are advised to seek independent professional advice before making any investments. The Fund’s prospectus is available on this website.
- References to particular sectors, securities or companies are for general information and illustrative purposes only and are not recommendations to buy or sell a security, or an indication of the issuer’s holdings at any one time.
- The funds or securities referred to herein are not sponsored, endorsed, or promoted by Solactive China Biotech Index NTR (”Solactive”), and Solactive bears no liability with respect to any such funds or securities or any index on which such funds or securities are based. The Fund’s prospectus contains a more detailed description of the limited relationship Solactive has with Mirae Asset HK and any related funds.
- Investors should note that the Fund differs from a typical retail fund as units of the Fund may only be created and realized by participating dealers in large unit sizes. This website is prepared and maintained by Mirae Asset HK and has not been reviewed by the Securities and Futures Commission of Hong Kong.